Zerenia Clinic Receives First NHS Reimbursement for Cannabis-Based Treatment

Zerenia Clinics has achieved a new milestone for by receiving full reimbursement from the UK’s NHS for costs related to cannabis-based treatments. The company, owned by Khiron, noted that the reimbursement is their first of its kind for outside clinics that specialize in cannabis-based products for medicinal use in humans (CBMPs).

According to Khiron, “This ground-breaking step validates Khiron’s scientific and data-driven approach to demonstrate the efficacy, safety and cost-effectiveness of CBMPs on the management of chronic conditions such as pain and anxiety. The Company, who continues to train doctors on the prescription of CBMPs, will be presenting its real-world evidence (RWE) at the upcoming International Congress on Clinical Trials on Cannabis to an international audience of medical doctors in London’s Canary Wharf on mid-February.”

To read more, click here.

(Source: Yahoo, January 17^th, 2022)